Combo Treatment, Including Lung-Sparing Surgery, Helps Mesothelioma Patients...
A combination of lung-sparing surgery, chemotherapy, and using light to kill malignant cells helped patients with malignant pleural mesothelioma live years longer than those who received chemotherapy...
View ArticlePostoperative Radiotherapy Benefits Limited for Sarcomatoid MPM Patients,...
Postoperative radiotherapy has limited survival benefits for certain patients with malignant pleural mesothelioma (MPM) who have had surgery to remove the cancer, researchers said in a recent...
View ArticleStudy Links Poverty to Shorter Survival for Mesothelioma Patients
Poor people with mesothelioma live shorter lives and are less likely to get chemotherapy than those with higher incomes, though geographical distance to oncological specialty care has no effect on...
View ArticleLong-term Chemo Improves Abdominal Mesothelioma Patients’ Survival Rates,...
Long-term localized chemotherapy may significantly improve survival in patients with malignant peritoneal mesothelioma (MPM), according to a study. The research, “Long-Term Regional Chemotherapy For...
View ArticleBenefits of Keytruda in Early Pleural Mesothelioma Trial Justifies Further...
Keytruda (pembrolizumab) may benefit patients with with malignant pleural mesothelioma by targeting tumors that produce the immune checkpoint molecule PD-L1, according to an interim analysis of a Phase...
View ArticleCheckpoint Molecule Measurements Not Reliable for Mesothelioma Research,...
Examining the presence of PD-L1 molecules in a tumor as a test to predict if therapy with immune checkpoint inhibitors will work is a highly controversial area in this field of research, according to...
View ArticleMicroRNAs Help Predict Pleural Mesothelioma Outcomes, European Study Finds
European researchers have identified two microRNAs, or small non-coding RNA molecules, that can be used to predict outcomes of malignant pleural mesothelioma, in an international study that aimed to...
View ArticleChemotherapy Effective in Peritoneal Mesothelioma, But Surgery Also Needs...
Aggressive malignant peritoneal mesothelioma responds to treatment with Alimta (pemetrexed) and Platinol (cisplatin) chemotherapy, reports a study examining patient outcomes. But more studies are...
View ArticleAnetumab Ravtansine Is Unable to Outperform Vinorelbine as a Mesothelioma...
Bayer’s anetumab ravtansine failed to improve the time it took for mesothelioma patients’ disease to progress, compared with another chemotherapy, according to a Phase 2 clinical trial. The results...
View ArticleAstraZeneca’s Mesothelioma Therapy Tremelimumab Disappoints in Phase 2b...
A Phase 2b clinical trial of AstraZeneca’s mesothelioma therapy tremelimumab showed no significant difference in survival times between treated and untreated patients. In addition, five of the treated...
View Article
More Pages to Explore .....